The lessons that enable firms to direct and accelerate their own
Table of Contents
Part 1: The Future of Pharma - Reprise
1. Introduction and an Invitation to Skip a Chapter
2. An Important Industry at Risk
3. The Best Idea Anyone Has Ever Had
4. The Biologists Got There First
5. Applying Evolutionary Theory to the Pharmaceutical and Medical Technology Sectors
6. Explaining the Industry’s Past
7. Predicting the Future of Pharma and Medtech
8. Practical Implications for an Evolving Industry
9. Watching the Future Unfold
Part 2: An Immeasurably Superior Power
10. Introduction: The Emergent Pressures of Selection
11. Selection Pressures Emerging from the Social Environment
12. Selection Pressures Emerging from the Technological Environment
13. Asking the Right Questions
Part 3: Evolution is Cleverer Than You Are
14. Introduction: Orgel’s Second Law
15. Technological Innovator Species Emerging in the Government Payer Habitat
16. Technological Innovator Species Emerging in Patient Payer Habitats
17. Operationally Excellent Species Emerging in the Government Payer Habitat
18. Operationally Excellent Species Emerging in Patient Payer Habitats
19. Customer Intimate Species Emerging in the Government Payer Habitat
20. Customer Intimate Species Emerging in Patient Payer Habitats
21. A Big Bang of Life Science Business Models
Part 4: Guiding the Blind Watchmaker
22. Introduction: From Description to Prescription
23. Which Fitness Peak(s) Should We Climb?
24. What Capabilities Does Our New Business Model Need?
25. How Should We Design a Capable Holobiont?
26. How Do We Build Our Core Capabilities?
